Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.344SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.556SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.245SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.403SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.636SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.126SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JD.1.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBC.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FY.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.31.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GK.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.27SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.3.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FD.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.44SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GN.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FW.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FY.1.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.3.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1.1.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.27SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EK.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.6.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DV.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.23.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.64SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.68SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.65 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.466SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
L.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.339SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.229SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.415SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.370SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.421SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.428.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.612SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.305SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FY.1.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GA.8.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.34SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HC.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.512SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.349SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.265SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.401SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.362SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GK.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FW.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used